CX3CR1信号在胶质瘤恶性转化中的作用
研究纳入90例低级别胶质瘤患者,检测CX3CR1 V249I多态性并分析其与生存、基因表达及肿瘤微环境的关系,同时利用基因工程小鼠模型验证CX3CL1/CX3CR1信号的作用。结果发现V/I或I/I基因型患者中位总生存期(14.8 vs 9.8年)和无进展生存期(8.6 vs 6.5年)均优于V/V野生型,且肿瘤CCL2、MMP9转录水平降低,M2巨噬细胞浸润和微血管密度减少;小鼠模型中共表达CX3CL1和CX3CR1促进更恶性表型、增加小胶质细胞/巨噬细胞浸润和微血管密度并缩短生存期。结论认为CX3CR1 V249I多态性与低级别胶质瘤生存改善相关,CX3CR1信号促进肿瘤相关小胶质细胞/巨噬细胞积聚和血管生成。
要点
- CX3CR1 V249I杂合或纯合患者中位总生存期14.8年,优于野生型9.8年(P<0.05)。
- V/I+I/I组中位无进展生存期8.6年,优于V/V组6.5年(P<0.05)。
- 小鼠模型中共表达CX3CL1和CX3CR1促进更恶性表型并缩短生存期。
核心结论
- CX3CR1 V249I多态性与低级别胶质瘤总生存期和无进展生存期改善相关。
- CX3CR1信号在恶性转化过程中促进肿瘤相关小胶质细胞/巨噬细胞积聚和血管生成。
研究设计与样本
- 对90例低级别胶质瘤患者进行CX3CR1 V249I多态性基因分型,分析基因型依赖的生存、基因表达和肿瘤微环境改变。
- 利用基因工程小鼠模型模拟内生颅内胶质瘤,分别或联合靶向表达CX3CL1和CX3CR1。
主要发现
- V/I杂合(n=43)或I/I纯合(n=2)患者中位总生存期14.8年 vs V/V野生型(n=45)9.8年(P<0.05),中位无进展生存期8.6年 vs 6.5年(P<0.05)。
- V/I+I/I组肿瘤CCL2和MMP9转录水平显著降低,与瘤内M2巨噬细胞浸润和微血管密度减少相关。
- 免疫健全小鼠低级别胶质瘤模型中共表达CX3CL1和CX3CR1促进更恶性肿瘤表型,表现为小胶质细胞/巨噬细胞浸润和微血管密度增加,导致生存期缩短。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chemokine signaling may contribute to progression of low-grade gliomas (LGGs) by altering tumor behavior or impacting the tumor microenvironment. In this study, we investigated the role of CX3C chemokine receptor 1 (CX3CR1) signaling in malignant transformation of LGGs. METHODS: Ninety patients with LGGs were genotyped for the presence of common CX3CR1 V249I polymorphism and examined for genotype-dependent alterations in survival, gene expression, and tumor microenvironment. A genetically engineered mouse model was leveraged to model endogenous intracranial gliomas with targeted expression of CX3C ligand 1 (CX3CL1) and CX3CR1, individually or in combination. RESULTS: LGG patients who were heterozygous (V/I; n = 43) or homozygous (I/I; n = 2) for the CX3CR1 V249I polymorphism had significantly improved median overall (14.8 vs 9.8 y, P < 0.05) and progression-free survival (8.6 vs 6.5 y, P < 0.05) compared with those with the wild type genotype (V/V; n = 45). Tumors from the V/I + I/I group exhibited significantly decreased levels of CCL2 and MMP9 transcripts, correlating with reduced intratumoral M2 macrophage infiltration and microvessel density. In an immunocompetent mouse model of LGGs, coexpression of CX3CL1 and CX3CR1 promoted a more malignant tumor phenotype characterized by increased microglia/macrophage infiltration and microvessel density, resulting in shorter survival. CONCLUSIONS: CX3CR1 V249I polymorphism is associated with improved overall and progression-free survival in LGGs. CX3CR1 signaling enhances accumulation of tumor associated microglia/macrophages and angiogenesis during malignant transformation.
引用
- Lee S, Latha K, Manyam G, et al. Role of CX3CR1 signaling in malignant transformation of gliomas. Neuro Oncol. 2020. PMID: 32236410. doi:10.1093/neuonc/noaa075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。